ALBUMINURIA
Clinical trials for ALBUMINURIA explained in plain language.
Never miss a new study
Get alerted when new ALBUMINURIA trials appear
Sign up with your email to follow new studies for ALBUMINURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a diabetes drug shield kidneys in sickle cell disease?
Disease control Not yet recruitingThis study tests whether empagliflozin, a drug already approved for kidney disease, can slow kidney damage in people with sickle cell anemia. About 20 adults with sickle cell disease and early signs of kidney trouble will take the drug for several months. Researchers will measure…
Matched conditions: ALBUMINURIA
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Can a diabetes drug shield teen kidneys? new trial aims to find out.
Disease control Not yet recruitingThis study tests whether a daily pill called dapagliflozin can reduce protein leakage in the urine of teenagers with mild-to-moderate chronic kidney disease. About 200 adolescents aged 14 to 18 will receive either the drug or a placebo for six months. The goal is to see if the dr…
Matched conditions: ALBUMINURIA
Phase: PHASE4 • Sponsor: Centenario Hospital Miguel Hidalgo • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC